MedTrace Logo

Attain Stability™ Quad Clinical Study

NCT03099655 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 471

Last updated 2020-01-09

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical study is to evaluate the safety and efficacy of the Attain Stability Quadripolar MRI SureScan Left Ventricular (LV) lead (Model 4798).

Conditions

Interventions

DEVICE

Attain Stability Quad Left Ventricular Pacing Lead

cardiac stimulation

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • George Crossley III, MD · Vanderbilt University Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-07
Primary Completion
2018-08-02
Completion
2019-05-31
FDA Device
Yes

Countries

  • United States
  • Canada
  • Germany
  • Hong Kong
  • Italy
  • Malaysia
  • Netherlands
  • Norway
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03099655 on ClinicalTrials.gov